Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AXDXNASDAQ:HLTHNASDAQ:OMIC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAXDXAccelerate Diagnostics$0.65$0.03▼$2.09$857K0.22513,448 shs53.64 million shsHLTHCue Health$0.04-29.8%$0.07$0.04▼$0.74$6.91M1.0913.38 million shs96.00 million shsOMICSingular Genomics Systems$20.01$20.01$5.34▼$23.41$50.83M1.8349,087 shsN/A2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAXDXAccelerate Diagnostics0.00%0.00%0.00%-96.11%-96.84%HLTHCue Health0.00%0.00%0.00%0.00%0.00%OMICSingular Genomics Systems0.00%0.00%0.00%0.00%+90.35%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAXDXAccelerate DiagnosticsN/AN/AN/AN/AN/AN/AN/AN/AHLTHCue HealthN/AN/AN/AN/AN/AN/AN/AN/AOMICSingular Genomics SystemsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAXDXAccelerate Diagnostics 4.00Strong BuyN/AN/AHLTHCue Health 0.00N/AN/AN/AOMICSingular Genomics Systems 2.00Hold$6.50-67.52% DownsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAXDXAccelerate Diagnostics$11.70M0.00N/AN/A($1.37) per share0.00HLTHCue Health$70.94M0.10N/AN/A$1.62 per share0.03OMICSingular Genomics Systems$2.91M17.47N/AN/A$73.25 per share0.27Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAXDXAccelerate Diagnostics-$61.62M-$2.34N/AN/AN/A-471.83%N/A-191.66%N/AHLTHCue Health-$373.46M-$2.44N/AN/AN/A-526.48%-67.82%-53.79%N/AOMICSingular Genomics Systems-$94.82M-$35.11N/A∞N/A-3,237.89%-57.87%-37.90%8/12/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAXDXAccelerate DiagnosticsN/AN/AN/AN/AN/AHLTHCue HealthN/AN/AN/AN/AN/AOMICSingular Genomics SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAXDXAccelerate DiagnosticsN/A1.501.34HLTHCue HealthN/A2.542.22OMICSingular Genomics Systems0.047.376.67Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAXDXAccelerate Diagnostics17.14%HLTHCue Health45.49%OMICSingular Genomics Systems65.80%Insider OwnershipCompanyInsider OwnershipAXDXAccelerate Diagnostics43.60%HLTHCue Health12.50%OMICSingular Genomics Systems22.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAXDXAccelerate Diagnostics22025.21 million14.13 millionOptionableHLTHCue Health726159.09 million139.21 millionOptionableOMICSingular Genomics Systems2202.54 million1.97 millionNo DataAXDX, OMIC, and HLTH HeadlinesRecent News About These CompaniesSingular Genomics highlights G4X milestones at AGBTFebruary 24, 2025 | markets.businessinsider.comSingular Highlights Key G4X™ Launch Milestones and Showcases Groundbreaking 3D Spatial Multiomic Performance at AGBTFebruary 24, 2025 | markets.businessinsider.comSingular Genomics announces closing of acquisition by Deerfield ManagmentFebruary 22, 2025 | markets.businessinsider.comSingular Genomics Shareholders Approve Merger AgreementFebruary 22, 2025 | investing.comSingular Genomics Systems, Inc. Closes Acquisition by Deerfield Management CompanyFebruary 21, 2025 | quiverquant.comSingular Genomics Announces Closing of Acquisition by Deerfield ManagementFebruary 21, 2025 | globenewswire.comSingular Genomics Systems IncFebruary 20, 2025 | morningstar.comAndrew Spaventa Sells 800 Shares of Singular Genomics Systems, Inc. (NASDAQ:OMIC) StockFebruary 15, 2025 | insidertrades.comSingular genomics CEO sells shares worth $15,912February 14, 2025 | msn.comSingular Genomics faces lawsuits over merger disclosuresFebruary 13, 2025 | msn.com(OMIC) Trading ReportFebruary 11, 2025 | news.stocktradersdaily.comGenomics Market to Grow by USD 5.21 Billion (2024-2028), Boosted by Rising Investments in R&D, with AI Impacting Market Trends - TechnavioJanuary 31, 2025 | uk.finance.yahoo.comInvestors With Losses Are Invited To Join The Schall Law Firm In An Investigation Into Singular Genomics Systems, Inc. For Securities FraudJanuary 30, 2025 | accessnewswire.comSingular Genomics Systems, Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Shareholders With Losses To Reach OutJanuary 29, 2025 | accessnewswire.comOMIC Investors Have the Opportunity to Join Investigation of Singular Genomics Systems, Inc. with the Schall Law FirmJanuary 28, 2025 | prnewswire.comSingular Genomics Systems, Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach OutJanuary 27, 2025 | accessnewswire.comInvestors Are Invited To Join The Schall Law Firm In An Inquiry Into Singular Genomics Systems, Inc. For Securities FraudJanuary 26, 2025 | accessnewswire.comSingular Genomics Systems, Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach OutJanuary 25, 2025 | accessnewswire.comInvestors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into Singular Genomics Systems, Inc. For Securities FraudJanuary 24, 2025 | accessnewswire.comSingular Genomics Systems, Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach OutJanuary 23, 2025 | accessnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeHigher Gulf Oil Output Puts These Energy Names in PlayBy Gabriel Osorio-Mazilli | June 13, 2025View Higher Gulf Oil Output Puts These Energy Names in PlayMore Than a Monetary Metal: Silver's Case for OutperformanceBy Jeffrey Neal Johnson | June 22, 2025View More Than a Monetary Metal: Silver's Case for OutperformanceWhich U.S. Towns See Economic Change First? [2025 Survey]By MarketBeat Staff | June 9, 2025View Which U.S. Towns See Economic Change First? [2025 Survey]AXDX, OMIC, and HLTH Company DescriptionsAccelerate Diagnostics NASDAQ:AXDX$0.04 +0.04 (+∞) As of 05/14/2025 This is a fair market value price provided by Polygon.io. Learn more.Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.Cue Health NASDAQ:HLTHCue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories. The company also provides COVID-19 testing kits. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.Singular Genomics Systems NASDAQ:OMIC$20.01 0.00 (0.00%) As of 02/21/2025Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
